Ekso Bionics Holdings Cash Flow from Financial Activities 2013-2024 | EKSO
Ekso Bionics Holdings cash flow from financial activities from 2013 to 2024. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
| Ekso Bionics Holdings Annual Cash Flow Financial (Millions of US $) |
|
|---|---|
| 2024 | $8 |
| 2023 | $0 |
| 2022 | $N/A |
| 2021 | $39 |
| 2020 | $11 |
| 2019 | $19 |
| 2018 | $2 |
| 2017 | $43 |
| 2016 | $23 |
| 2015 | $14 |
| 2014 | $41 |
| 2013 | $9 |
| 2013 | $0 |
| 2012 | $15 |
| 2012 | $N/A |
| 2011 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.014B | $0.018B |
| Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company's operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western Europe, the Middle East and South Africa. Ekso Bionics Holdings, Inc. is headquartered in Richmond, California. | |||